RAPT Therapeutics, Inc.

UBS Group AG RAPT

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/13/2025

Shares

160,836

Value ($000)

196

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/13/2025	196	0.0%	160,836	3/31/2025
2024 Q4	2/14/2025	236	0.0%	149,669	12/31/2024
2024 Q3	11/14/2024	58	0.0%	28,846	9/30/2024
2024 Q2	8/14/2024	87	0.0%	28,588	6/30/2024
2024 Q1	5/13/2024	499	0.0%	55,567	3/31/2024
2023 Q4	2/9/2024	2,237	0.0%	90,010	12/31/2023
2023 Q3	11/9/2023	570	0.0%	34,304	9/30/2023
2023 Q2	8/11/2023	886	0.0%	47,400	6/30/2023
2023 Q1	5/12/2023	896	0.0%	48,805	3/31/2023
2022 Q4	2/8/2023	1,975	0.0%	99,744	12/31/2022
2022 Q3	11/10/2022	277	0.0%	11,515	9/30/2022
2022 Q2	8/10/2022	49	0.0%	2,691	6/30/2022
2022 Q1	5/16/2022	989	0.0%	44,962	3/31/2022
2021 Q4	2/14/2022	2,869	0.0%	78,113	12/31/2021
2021 Q3	11/15/2021	193	0.0%	6,230	9/30/2021
2021 Q2	8/13/2021	196	0.0%	6,178	6/30/2021
2021 Q1	5/12/2021	199	0.0%	8,976	3/31/2021
2020 Q4	2/11/2021	160	0.0%	8,101	12/31/2020
2020 Q3	11/12/2020	626	0.0%	19,417	9/30/2020
2020 Q2	7/31/2020	451	0.0%	15,564	6/30/2020
2020 Q1	5/1/2020	34	0.0%	1,588	3/31/2020
2019 Q4	2/14/2020	81	0.0%	2,934	12/31/2019